Advances in the treatment of relapsing - Remitting multiple sclerosis

Advances in the treatment of relapsing - Remitting multiple sclerosis

This article reviews and discusses the approved and emerging therapies for multiple sclerosis (MS). MS is a chronic and disabling immune-mediated disease of the central nervous system (CNS) that affects mainly young adults. MS imposes a huge economic burden on healthcare systems and the society. Alt...

Full description

Bibliographic Details
Main Authors: Radu Tanasescu, Carolina Ionete, I-Jun Chou, Cris S Constantinescu
Format: Article
Language:English
Published: Elsevier 2014-04-01
Series:Biomedical Journal
Subjects:
disease-modifying treatments
monoclonal antibodies
multiple sclerosis
oral drugs
Online Access:http://www.biomedj.org/article.asp?issn=2319-4170;year=2014;volume=37;issue=2;spage=41;epage=49;aulast=Tanasescu

Internet

http://www.biomedj.org/article.asp?issn=2319-4170;year=2014;volume=37;issue=2;spage=41;epage=49;aulast=Tanasescu

Similar Items